2010 SSO John Wayne Clinical research lecture: Rectal cancer outcome improvements in Europe: Population-based outcome registrations will conquer the world

Annals of Surgical Oncology

Volumn 18, Issue 3, 2011, Pages 691-696

  Van Gijn, W ^a   Van De Velde, C J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); EUROPE; HUMAN; MEDICAL AUDIT; POPULATION RESEARCH; POSTOPERATIVE CARE; QUALITY CONTROL; RECTUM CANCER; TREATMENT OUTCOME;

EUROPE; HUMANS; QUALITY IMPROVEMENT; QUALITY OF HEALTH CARE; RECTAL NEOPLASMS; REGISTRIES; TREATMENT OUTCOME;

EID: 79955706245     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1326-3     Document Type: Article

References (33)

1. Gatta G, Faivre J, Capocaccia R, Ponz de LM. Survival of colorectal cancer patients in Europe during the period 1978-1989. Eur J Cancer. 1998;34(14):2176-83. (Pubitemid 29036883)
2. Birgisson H, Talback M, Gunnarsson U, Pahlman L, Glimelius B. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol. 2005;31(8):845-53. (Pubitemid 41435253)
3. van Gijn W, Krijnen P, Lemmens VE, den DM, Putter H, van de Velde CJ. Quality assurance in rectal cancer treatment in the Netherlands: A catch up compared to colon cancer treatment. Eur J Surg Oncol. 2010;36(4):340-4.
4. Pahlman L, Glimelius B. Local recurrences after surgical treatment for rectal carcinoma. Acta Chir Scand. 1984;150(4):331-5. (Pubitemid 14110140)
5. Pahlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg. 1990;211(2):187-95. (Pubitemid 20063206)
6. Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer. 1995 75 9 2269-75.
7. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: Long-term follow-up of a population-based study. Cancer. 2001;92(4):896-902. (Pubitemid 32783078)
8. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med. 1997 336 14 980-7.
9. Heald RJ. A new approach to rectal cancer. Br J Hosp Med. 1979 22 3 277-81. (Pubitemid 10229935)
10. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg. 1982 69 10 613-6.
11. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638-46.
12. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumor spread and surgical excision. Lancet. 1986;2(8514):996-9.
13. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246(5):693-701. (Pubitemid 350035641)
14. den Dulk M, Krijnen P, Marijnen CA, et al. Improved overall survival for patients with rectal cancer since 1990: The effects of TME surgery and pre-operative radiotherapy. Eur J Cancer. 2008 44 12 1710-6.
15. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004 351 17 1731-40.
16. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol. 2004;72(1):15-24. (Pubitemid 38952855)
17. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006;93(10):1215-23. (Pubitemid 44547018)
18. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet. 2009;373(9666): 811-20.
19. Akasu T, Moriya Y, Ohashi Y, Yoshida S, Shirao K, Kodaira S. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: A multicenter randomized controlled trial. Jpn J Clin Oncol. 2006;36(4):237-44.
20. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006 355 11 1114-23. (Pubitemid 44394918)
21. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer. 2009 45 6 931-91.
22. Birkmeyer JD, Finlayson EV, Birkmeyer CM. Volume standards for high-risk surgical procedures: Potential benefits of the Leapfrog initiative. Surgery. 2001;130(3):415-22. (Pubitemid 32868450)
23. Wibe A, Moller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum. 2002;45(7):857-66. (Pubitemid 34761463)
24. Wibe A. Nationwide quality assurance of rectal cancer treatment. Colorectal congress, 28th November 2007, St Gallen, Switzerland, 2007.
25. Harling H, Bulow S, Kronborg O, Moller LN, Jorgensen T. Survival of rectal cancer patients in Denmark during 1994-99. Colorectal Dis. 2004;6(3):153-7. (Pubitemid 38660633)
26. Report of The National Bowel Cancer Audit Programme "NBOCAP Report 2009." http://www.nbocap.org.uk/resources/reports/NBOCAP-2009pdf 2009.
27. Mroczkowski P, Kube R, Schmidt U, Gastinger I, Lippert H. Quality assessment of colorectal cancer care-an international online model. Colorectal Dis. 2010. [Epub ahead of print].
28. Penninckx F, Van EL, Michiels G, et al. Survival of rectal cancer patients in Belgium 1997-98 and the potential benefit of a national project. Acta Chir Belg. 2006;106(2):149-57. (Pubitemid 43709756)
29. Spanish TME project 2006-2008. http://www.aecirujanos.es/ secciones/coloproctologia/proyecto-vikingo-informe-2006-2008. pdf 2010.
30. Dutch Surgical Colorectal Audit: Report 2009. http://www.dsca. nl/images/documenten/jaarrapportage%20DSCA.pdf 2009.
31. Marijnen CA, Nagtegaal ID, Klein KE, et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol. 2001;19(7):1976-84. (Pubitemid 32702542)
32. Pettersson D, Cedermark B, Holm T, et al. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg. 2010;97(4):580-7.
33. Harken AH. Surgical research promotes world peace. Ann Surg. 2007 245 4 524-5. (Pubitemid 46555653)